Smiths Detection has entered into a global distribution agreement with 20/20 BioResponse for its BioCheck powder screening test kits, expanding its offerings to emergency and first responders. “This partnership reinforces our goal of becoming a total solutions provider for biological threat assessment,” says Mal Maginnis, president, Global Military and Emergency Responders for Smiths Detection. “BioCheck complements our line of suspicious powders assessment technologies giving emergency responders a comprehensive suite to choose from for quick, efficient and accurate detection in suspicious powder incidents.” BioCheck is a protein assay and pH test for rapid assessment of suspicious powders representing potential biological threats. 20/20 BioResponse is a division of Maryland-based 20/20 GeneSystems.